Experience With Subcutaneous Abatacept for Rheumatoid Arthritis: An Update for Clinicians

Therapeutic Advances in Musculoskeletal Disease - United States
doi 10.1177/1759720x14551567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

A Critical Evaluation of the Role of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis: Patient Considerations

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2014English

Abatacept: The Evidence for Its Place in the Treatment of Rheumatoid Arthritis

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Malignancies in the Rheumatoid Arthritis Abatacept Clinical Development Programme: An Epidemiological Assessment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

Journal of Clinical Medicine
2019English

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Abatacept: A T-Cell Co-Stimulation Modulator for the Treatment of Rheumatoid Arthritis

Clinical Rheumatology
MedicineRheumatology
2008English

Painful Diabetic Neuropathy (PDN): An Update for Clinicians

The Bangkok Medical Journal
2013English

Circulating Th17.1 Cells as Candidate for the Prediction of Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis: An Exploratory Research

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy